These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 28331926

  • 1. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.
    Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F.
    Thromb Haemost; 2017 Jun 27; 117(7):1448-1454. PubMed ID: 28331926
    [Abstract] [Full Text] [Related]

  • 2. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.
    Gallego P, Roldan V, Marín F, Romera M, Valdés M, Vicente V, Lip GY.
    Thromb Haemost; 2013 Dec 27; 110(6):1189-98. PubMed ID: 24096615
    [Abstract] [Full Text] [Related]

  • 3. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P, Roldán V, Torregrosa JM, Gálvez J, Valdés M, Vicente V, Marín F, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 27; 5(2):312-8. PubMed ID: 22319005
    [Abstract] [Full Text] [Related]

  • 4. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
    Potpara TS, Lip GY.
    Prog Cardiovasc Dis; 2015 Apr 27; 58(2):177-94. PubMed ID: 26162958
    [Abstract] [Full Text] [Related]

  • 5. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G, Ducrocq G, Elbez Y, Van Belle E, Goto S, Cannon CP, Bauters C, Bhatt DL, Steg PG, REACH Investigators.
    Clin Cardiol; 2017 Oct 27; 40(10):932-939. PubMed ID: 28692742
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O, Durand E, Muñoz-García AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benítez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elízaga J, Dager A, García Del Blanco B, Ortas-Nadal Mdel R, Marsal JR, Campelo-Parada F, Regueiro A, Del Trigo M, Dumont E, Puri R, Rodés-Cabau J.
    JACC Cardiovasc Interv; 2016 Aug 22; 9(16):1706-17. PubMed ID: 27539691
    [Abstract] [Full Text] [Related]

  • 8. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW, Kim S, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, Singer DE, Mahaffey KW, Kowey PR, Thomas L, Go AS, Lopes RD, Chang P, Peterson ED, Gersh BJ, ORBIT-AF Investigators.
    Circ Cardiovasc Qual Outcomes; 2013 Jul 22; 6(4):461-9. PubMed ID: 23759473
    [Abstract] [Full Text] [Related]

  • 9. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM, Marín F, Roldán V, Valencia J, Manzano-Fernández S, Caballero L, Hurtado JA, Sogorb F, Valdés M, Lip GY.
    Circ Cardiovasc Interv; 2012 Aug 01; 5(4):459-66. PubMed ID: 22787018
    [Abstract] [Full Text] [Related]

  • 10. Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation).
    Patti G, Lucerna M, Pecen L, Siller-Matula JM, Cavallari I, Kirchhof P, De Caterina R.
    J Am Heart Assoc; 2017 Jul 23; 6(7):. PubMed ID: 28736385
    [Abstract] [Full Text] [Related]

  • 11. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G, Sartipy U, Friberg L, Dahlström U, Lund LH.
    Heart; 2018 Jul 23; 104(13):1093-1100. PubMed ID: 29371374
    [Abstract] [Full Text] [Related]

  • 12. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan　- Findings From the AF Frontier Ablation Registry.
    Okumura Y, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, AF Ablation Frontier Registry.
    Circ J; 2019 Nov 25; 83(12):2418-2427. PubMed ID: 31619591
    [Abstract] [Full Text] [Related]

  • 13. Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
    Verheugt FWA, Ambrosio G, Atar D, Bassand JP, Camm AJ, Costabel JP, Fitzmaurice DA, Illingworth L, Goldhaber SZ, Goto S, Haas S, Jansky P, Kayani G, Stepinska J, Turpie AGG, van Eickels M, Kakkar AK, GARFIELD-AF Investigators.
    Am J Med; 2019 Dec 25; 132(12):1431-1440.e7. PubMed ID: 31306621
    [Abstract] [Full Text] [Related]

  • 14. Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.
    Olesen JB, Lip GY, Hansen PR, Lindhardsen J, Ahlehoff O, Andersson C, Weeke P, Hansen ML, Gislason GH, Torp-Pedersen C.
    J Thromb Haemost; 2011 Aug 25; 9(8):1460-7. PubMed ID: 21624047
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G.
    Europace; 2015 Dec 25; 17(12):1777-86. PubMed ID: 26321406
    [Abstract] [Full Text] [Related]

  • 18. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.
    Bertomeu-Gonzalez V, Moreno-Arribas J, Esteve-Pastor MA, Roldán-Rabadán I, Muñiz J, Raña-Míguez P, Ruiz-Ortiz M, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F, FANTASIIA Study Investigators.
    J Am Heart Assoc; 2020 Jan 07; 9(1):e013789. PubMed ID: 31870235
    [Abstract] [Full Text] [Related]

  • 19. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
    Freeman JV, Shrader P, Pieper KS, Allen LA, Chan PS, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Singer DE, Go AS, Hylek EM, Steinberg BA, Peterson ED, Piccini JP.
    Circ Arrhythm Electrophysiol; 2019 Dec 07; 12(12):e007612. PubMed ID: 31830822
    [Abstract] [Full Text] [Related]

  • 20. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC, Kim S, Thomas L, Fonarow GC, Kowey PR, Mahaffey KW, Gersh BJ, Piccini JP, Peterson ED.
    J Am Heart Assoc; 2016 May 04; 5(5):. PubMed ID: 27146448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.